Screener
Alnylam Pharmaceuticals ALNY Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's asset turnover?
- Alnylam Pharmaceuticals (ALNY) reported asset turnover of 0.9× in Q2 2026.
- How has Alnylam Pharmaceuticals's asset turnover changed year-over-year?
- Alnylam Pharmaceuticals's asset turnover increased by 65.3% year-over-year, from 0.6× to 0.9×.
- What is the long-term trend for Alnylam Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's asset turnover has grown at a 36.6% compound annual growth rate (CAGR), from 0.2× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Alnylam Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude